Canada Gains Access to Wegovy®, a New Treatment Option for Obesity

Discover the latest breakthrough in obesity treatment as Novo Nordisk launches Wegovy® in Canada on May 6, 2024. Learn how this once-weekly injection can transform obesity management and support millions of Canadians. Explore the effectiveness, safety data, and patient eligibility for Wegovy®.